Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a DUSP9 methylation screening assay.

Pathology oncology research : POR - 1 Jan 2015

Jenner Stefan, Wiedorn Klaus Herrmann, Techel Dieter

Abstract excerpt

A methylation screening assay for DUSP9 (dual-specificity phosphatase 9) has been developed and applied on 79 FFPE samples from patients with colorectal cancer (CRC) and 22 corresponding tumor free colon samples in this study. Quantitative pyrosequencing was used for the determination of the methylation in the promoter CpG island, including 83 CpG motifs. In this way, the methylation pattern of the 11 tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Assay
Share to Colon
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CpG Islands

Share to Dual-Specificity Phosphatases

Share to Methylation

Share to Phenotype

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 24838152
DOI: 10.1007/s12253-014-9797-3

Genes

DUSP9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a DUSP9 methylation screening assay.PMID 24838152Read ↗

Toward a comprehensive and systematic methylome signature in colorectal cancersSemantic proximity Read ↗

Downregulation of Dual-specificity phosphatase 9 promotes tumor progression and contributes to poor prognosis in colorectal cancerSemantic proximity Read ↗

Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencingSemantic proximity Read ↗

DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.Semantic proximity Read ↗

Unique DNA methylome profiles in CpG island methylator phenotype colon cancers.Semantic proximity Read ↗

DUSP10 gene polymorphism and risk of colorectal cancer in the Han Chinese population.Semantic proximity Read ↗

Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.Semantic proximity Read ↗

DNA Methylation Analysis Using Bisulfite Pyrosequencing.Semantic proximity Read ↗

Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancerSemantic proximity Read ↗

Allele-Specific DNA Methylation Detection by Pyrosequencing®.Semantic proximity Read ↗

DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.Semantic proximity Read ↗

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarraysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.